×
For best experience we recommend to activate Javascript in your browser.
MIA2 antibody (C-Term)
This anti-MIA2 antibody is a Rabbit Polyclonal antibody detecting MIA2 in WB and IHC (p). Suitable for Human.
Quick Overview for MIA2 antibody (C-Term) (ABIN656676)
Target
See all MIA2 Antibodies
MIA2
(Melanoma Inhibitory Activity Protein 2 (MIA2))
Reactivity
All reactivities for MIA2 antibodies
Human
Host
All hosts for MIA2 antibodies
Rabbit
Clonality
All clonalities for MIA2 antibodies
Polyclonal
Conjugate
All conjugates for MIA2 antibodies
This MIA2 antibody is un-conjugated
Application
All applications for MIA2 antibodies
Western Blotting (WB), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
Clone
RB32440
Product Details anti-MIA2 Antibody
(hide)
Binding Specificity
All epitopes for MIA2 antibodies
AA 775-804, C-Term
Purification
This antibody is purified through a protein A column, followed by peptide affinity purification.
Immunogen
This CTAGE5 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 775-804 amino acids from the C-terminal region of human CTAGE5.
Isotype
Ig Fraction
Alternatives
(show)
Application Details
(hide)
Application Notes
WB: 1:1000. IHC-P: 1:10~50
Restrictions
For Research Use only
Handling
(hide)
Format
Liquid
Buffer
Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.
Preservative
Sodium azide
Precaution of Use
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage
4 °C,-20 °C
Storage Comment
CTAGE5 Antibody (C-term) can be refrigerated at 2-8 °C for up to 6 months. For long term storage, place the at -20 °C.
Expiry Date
6 months
Target Details for MIA2
(hide)
Target
MIA2
(Melanoma Inhibitory Activity Protein 2 (MIA2))
Alternative Name
CTAGE5
Background
CTAGE5 is a tumor-associated antigen.
Gene ID
4253
NCBI Accession
NP_001234917 , NP_001234918 , NP_001234919 , NP_005921 , NP_976229 , NP_976231
UniProt
O15320
Recently viewed
(hide)
Chat with us , powered by LiveChat